Latest Breaking News On - Hillman cancer center - Page 1 : comparemela.com

Carolyn J Anderson, PhD, Receives SNMMI 2024 Georg Charles de Hevesy Nuclear Pioneer Award

Carolyn J Anderson, PhD, Receives SNMMI 2024 Georg Charles de Hevesy Nuclear Pioneer Award
itnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itnonline.com Daily Mail and Mail on Sunday newspapers.

United statesWashington universityMichaelj welchErnest lawrencePaulc aebersoldCarolynj andersonHelen nadelFlorida state universityMolecular imaging laboratoryGlennt seaborg award for nuclear chemistryUniversity of wisconsinAmerican association of cancer researchWorld molecular imaging societySociety of radiopharmaceutical sciencesAmerican chemical societyUniversity of pittsburgh

Another KRAS Inhibitor Scores an Early Win in Advanced Non-Small Cell Lung Cancer

Half of patients responded, but editorialists call for new directions in therapy development

United statesDana farber cancer instituteJia luoCharles bankheadLiza villaruzHillman cancer centerShanghai jiao tong universityLancet respiratoryCancer centerMedpage todayRespir med

Long-Term Data for Up-Front Combinations Reaffirm Treatment Options in CLL

Kathleen A. Dorritie, MD, discusses long-term data from trials in chronic lymphocytic leukemia presented at the 2023 ASH Annual Meeting.

United statesKathleena dorritieHillman cancer centerUniversity of pittsburghUniversity of pittsburgh medical centerDivision of oncologyPittsburgh medical centerObinutuzumab vsTreatment naive chronic lymphocytic leukemiaYear follow up

Myelofibrosis: Beyond Ruxolitinib

Other JAK inhibitors, combinations, and novel therapies offer more hope for patients

United statesJames rossettiMike bassettNaveen pemmarajuHillman cancer centerUniversity of texas md anderson cancer centerAmerican society of hematologyNational comprehensive cancer networkCancer centerAmerican society

Dr Foldi on T-DXd and Sacituzumab Govitecan in Metastatic Breast Cancer

Julia Foldi, MD, PhD, discusses the utility of of T-DXd and sacituzumab govitecan in the treatment of metastatic HER2-low and triple-negative breast cancer.

Julia foldiHillman cancer centerDepartment of medicineUniversity of pittsburg medical centerPittsburg medical centerCancer center